COMI, GIACOMO PIETRO
 Distribuzione geografica
Continente #
EU - Europa 54.962
NA - Nord America 50.307
AS - Asia 45.997
SA - Sud America 4.798
AF - Africa 1.049
OC - Oceania 487
Continente sconosciuto - Info sul continente non disponibili 71
Totale 157.671
Nazione #
US - Stati Uniti d'America 47.728
GB - Regno Unito 15.193
CN - Cina 14.817
SG - Singapore 12.406
IT - Italia 10.102
DE - Germania 7.788
SE - Svezia 4.294
RU - Federazione Russa 3.825
HK - Hong Kong 3.788
VN - Vietnam 3.273
BR - Brasile 3.260
FR - Francia 3.055
IN - India 2.516
BD - Bangladesh 1.969
CA - Canada 1.854
NL - Olanda 1.784
JP - Giappone 1.591
UA - Ucraina 1.558
TR - Turchia 1.545
IE - Irlanda 1.515
FI - Finlandia 1.476
KR - Corea 1.433
ES - Italia 889
EU - Europa 783
ID - Indonesia 642
PL - Polonia 581
CO - Colombia 535
AU - Australia 432
AR - Argentina 423
BE - Belgio 412
MX - Messico 412
DK - Danimarca 409
GR - Grecia 371
CH - Svizzera 361
CI - Costa d'Avorio 315
TW - Taiwan 278
AT - Austria 269
PT - Portogallo 215
IQ - Iraq 181
RO - Romania 178
ZA - Sudafrica 176
CL - Cile 164
EC - Ecuador 147
PK - Pakistan 145
IL - Israele 142
PH - Filippine 139
SA - Arabia Saudita 133
UZ - Uzbekistan 125
CZ - Repubblica Ceca 111
TH - Thailandia 111
EG - Egitto 109
MA - Marocco 105
MY - Malesia 102
IR - Iran 101
NO - Norvegia 99
VE - Venezuela 79
HU - Ungheria 70
PE - Perù 69
NP - Nepal 61
AE - Emirati Arabi Uniti 59
DZ - Algeria 58
TN - Tunisia 58
CR - Costa Rica 52
NZ - Nuova Zelanda 52
JO - Giordania 51
AZ - Azerbaigian 48
PY - Paraguay 48
KE - Kenya 45
LT - Lituania 45
HR - Croazia 42
JM - Giamaica 41
BG - Bulgaria 39
UY - Uruguay 39
PR - Porto Rico 36
SK - Slovacchia (Repubblica Slovacca) 35
KZ - Kazakistan 34
LU - Lussemburgo 33
KG - Kirghizistan 32
LB - Libano 32
RS - Serbia 32
BO - Bolivia 31
DO - Repubblica Dominicana 30
PS - Palestinian Territory 30
CY - Cipro 29
LV - Lettonia 29
LK - Sri Lanka 27
PA - Panama 27
SC - Seychelles 26
SI - Slovenia 25
ET - Etiopia 24
OM - Oman 23
AL - Albania 22
AM - Armenia 22
EE - Estonia 22
HN - Honduras 22
GE - Georgia 19
QA - Qatar 18
GT - Guatemala 16
MD - Moldavia 15
MK - Macedonia 15
Totale 158.027
Città #
Southend 12.525
Singapore 7.112
Ashburn 4.855
Chandler 3.371
Hong Kong 3.326
Milan 2.783
Beijing 2.740
San Jose 2.458
Seattle 2.189
Dallas 1.923
Frankfurt am Main 1.739
Wilmington 1.589
Fairfield 1.576
Princeton 1.527
Dublin 1.461
Council Bluffs 1.387
Los Angeles 1.157
Jacksonville 1.136
Ann Arbor 1.131
New York 1.072
Houston 1.043
Bengaluru 1.005
Toronto 919
Ho Chi Minh City 900
Woodbridge 891
Redwood City 802
Santa Clara 797
Hanoi 796
Nanjing 789
Hefei 735
Lauterbourg 721
Helsinki 684
Shanghai 679
Redmond 668
Cambridge 665
Tokyo 634
Guangzhou 621
Moscow 612
Mountain View 588
Dearborn 585
Buffalo 576
Des Moines 552
Boardman 531
Hanover 530
Rome 495
Munich 447
Jakarta 415
Sakarya 412
Warsaw 408
Bogotá 406
Serra 406
Andover 380
Phoenix 374
Jinan 361
Columbus 359
The Dalles 351
Somerville 345
São Paulo 344
Abidjan 314
Shenyang 289
Ottawa 278
Seoul 276
Changsha 275
Cangzhou 271
Athens 265
Berlin 265
Istanbul 263
London 261
Tianjin 261
Chicago 251
Hangzhou 237
Paris 216
Brussels 215
Grafing 215
Nanchang 212
Fuzhou 198
Madrid 192
Atlanta 189
Naples 186
Medford 180
Shenzhen 176
Nuremberg 174
Zhengzhou 171
Bologna 168
Hebei 168
Dong Ket 165
Turin 164
Bitonto 156
San Diego 156
Amsterdam 151
Kiez 150
Da Nang 147
Wuhan 144
Montreal 143
Boston 138
Washington 136
Mumbai 133
Taipei 129
Vienna 129
Chengdu 119
Totale 88.209
Nome #
Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS) 4.695
Time Is Motor Neuron: Therapeutic Window and Its Correlation with Pathogenetic Mechanisms in Spinal Muscular Atrophy 2.065
Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: A randomised, double-blind, placebo-controlled phase 2 trial 1.736
The Italian limb girdle muscular dystrophy registry : relative frequency, clinical features, and differential diagnosis 1.557
Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial 1.133
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements 1.028
Rhabdomyolysis-Associated Acute Kidney Injury 930
R-Loops in Motor Neuron Diseases 790
Development of Therapeutics for C9ORF72 ALS/FTD-related disorders 778
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD) 696
Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia 689
Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1) 661
"Mitochondrial neuropathies" : A survey from the large cohort of the Italian Network 594
Pathogenic TNNI1 variants disrupt sarcomere contractility resulting in hypo- and hypercontractile muscle disease 585
A de novo C19orf12 heterozygous mutation in a patient with MPAN 574
Noncoding RNAs in Duchenne and Becker muscular dystrophies: role in pathogenesis and future prognostic and therapeutic perspectives 531
Loss of the nucleoporin Aladin in central nervous system and fibroblasts of Allgrove Syndrome 522
The analysis of myotonia congenita mutations discloses functional clusters of amino acids within the CBS2 domain and the C-terminal peptide of the ClC-1 channel 513
Decline of ALS-FRS and Norris scale scores in a group of patients affected by ALS and treated with lithium 508
Neurofascin (NFASC) gene mutation causes autosomal recessive ataxia with demyelinating neuropathy 502
Pediatric anti-HMGCR necrotizing myopathy: diagnostic challenges and literature review 494
Anti-sulfatide reactivity in patients with celiac disease 467
Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study 451
Preconditioning and Cellular Engineering to Increase the Survival of Transplanted Neural Stem Cells for Motor Neuron Disease Therapy 448
SLC25A46 mutations in patients with Parkinson's Disease and optic atrophy 439
Neuromuscular excitability changes produced by sustained voluntary contraction and response to mexiletine in myotonia congenita 436
Advances, Challenges, and Perspectives in Translational Stem Cell Therapy for Amyotrophic Lateral Sclerosis 436
Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable? 425
Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons 423
Histological effects of givinostat in boys with Duchenne muscular dystrophy 422
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model 417
Metformin increases platelet lactate production by inhibiting mitochondrial function 416
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 416
Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms 390
Value of insoluble PABPN1 accumulation in the diagnosis of oculopharyngeal muscular dystrophy 387
La canalopatia del cloro : diagnosi clinica differenziale 386
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy 382
Molecular Approaches for the Treatment of Pompe Disease 382
Purkinje cell COX deficiency and mtDNA depletion in an animal model of spinocerebellar ataxia type 1 379
Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches 377
Asymptomatic Pompe disease : Can muscle magnetic resonance imaging facilitate diagnosis? 371
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model 363
Anti-MAG IgM: differences in antibody tests and correlation with clinical findings 361
Colocalization of ribonuclear inclusions with muscle blind like-proteins in a family with myotonic dystrophy type 2 associated with a short CCTG expansion 357
Herpes Simplex virus type 2 myeloradiculitis with a pure motor presentationin a liver transplant recipient 353
Clinical features and disease course of patients with acute ischaemic stroke just before the Italian index case: Was COVID-19 already there? 347
Can Intestinal Pseudo-Obstruction Drive Recurrent Stroke-Like Episodes in Late-Onset MELAS Syndrome? A Case Report and Review of the Literature 346
Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions 343
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models 343
Nusinersen treatment and cerebrospinal fluid neurofilaments : An explorative study on Spinal Muscular Atrophy type 3 patients 341
Neural stem cell transplantation for neurodegenerative diseases 341
A functional variant in ERAP1 predisposes to multiple sclerosis 330
Influence of the Glu298Asp polymorphism of NOS3 on age at aonset and homocysteine levels in AD patients 325
Outcome measures validation study for mesoangioblasts transplantation in children affected by Duchenne Muscular Dystrophy 325
Ophthalmoplegia due to Miller Fisher syndrome in a patient with myasthenia gravis 324
A case report with the peculiar concomitance of 2 different genetic syndromes 323
A novel homozygous VPS11 variant may cause generalized dystonia 321
Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease 320
Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of Andersen Disease associated with a new mutation in GBE1 gene 320
A Rare Cause of Juvenile Stroke: Extracranial Carotid Artery Aneurysm with Venous Complete Reconstruction of the Carotid Bifurcation 320
Mutations in TMEM230 are rare in autosomal dominant Parkinson's disease 319
Central nervous system involvement in common variable immunodeficiency: A case of acute unilateral optic neuritis in a 26 -year-old Italian Patient 318
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 317
Expanding the genotypic and phenotypic spectrum of Beta-propeller-associated neurodegeneration (BPAN) 314
Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies 312
Limb girdle muscular dystrophy due to LAMA2 gene mutations: new mutations expand the clinical spectrum of a still challenging diagnosis 310
Clinical and molecular characterization of a cohort of patients with novel nucleotide alterations of the Dystrophin gene detected by direct sequencing 309
The mitochondrial disulfide relay system protein GFER is mutated in autosomal recessive myopathy with congenital cataract and COX deficiency. 305
Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis 304
Muscle pain in mitochondrial diseases: a picture from the Italian network 299
Missense mutations in small muscle protein X-linked (SMPX) cause distal myopathy with protein inclusions 299
Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia 298
Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic 297
ISPD mutations account for a small proportion of Italian Limb Girdle Muscular Dystrophy cases 296
IPSC-derived neural stem cells act via kinase inhibition to exert neuroprotective effects in spinal muscular atrophy with respiratory distress type 1 293
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis 293
Myotonia congenita : novel mutations in CLCN1 gene and functional characterizations in Italian patients 292
The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease 290
Correzione dell’acidemia lattica transitoria mediante sodio bicarbonato: effetti dell’alcalinizzazione sulla via glicolitica 289
A case report of late-onset cerebellar ataxia associated with a rare p.R342W TGM6 (SCA35) mutation 286
Direct reprogramming of adult somatic cells into other lineages: past evidence and future perspectives 282
Charcot-Marie-Tooth disease type 2F associated with biallelic HSPB1 mutations 281
Diverse evolutionary histories for beta-adrenoreceptor genes in humans 279
Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature 279
Balancing selection is common in the extended MHC region but most alleles with opposite risk profile for autoimmune diseases are neutrally evolving 277
Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype 277
The mitochondrial disulfide relay system protein GFER is mutated in sutosomal-tecessive myopathy with vataract and vombined respiratory-chain deficiency 274
A complex selection signature at the human AVPR1B gene 273
Transplanted ALDH(hi)SSC(lo) neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1 273
Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia 273
Glial cells involvement in spinal muscular atrophy: Could SMA be a neuroinflammatory disease? 270
Amyotrophic lateral sclerosis linked to a novel SOD1 mutation with muscle mitochondrial dysfunction 269
Mitochondrial changes in platelets are not related to those in skeletal muscle during human septic shock 269
Animal Models of CMT2A: State-of-art and Therapeutic Implications 268
Association study between XRCC1 gene polymorphisms and sporadic amyotrophic lateral sclerosis 267
CSF transplantation of a specific iPSC-derived neural stem cell subpopulation ameliorates the disease phenotype in a mouse model of spinal muscular atrophy with respiratory distress type 1 267
Hereditary hemorrhagic telangiectasia associated with cortical development malformation due to a start loss mutation in ENG 267
The landscape of human genes involved in the immune response to parasitic worms 265
Expanding the clinical spectrum of the mitochondrial mutation A13084T in the ND5 gene 264
Mitochondrial DNA G8363A mutation in the tRNA Lys gene: clinical, biochemical and pathological study 263
Totale 47.711
Categoria #
all - tutte 414.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 414.733


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.116 0 0 0 0 0 0 0 0 0 0 2.028 1.088
2021/202211.968 900 708 578 871 840 884 935 797 1.503 1.097 870 1.985
2022/202313.979 1.729 1.422 1.017 1.460 1.507 2.398 501 931 1.528 394 696 396
2023/202411.606 483 804 805 809 2.317 791 749 875 481 801 1.197 1.494
2024/202524.466 1.232 2.238 895 2.524 1.727 1.138 1.183 2.371 1.660 2.333 2.352 4.813
2025/202645.810 4.679 3.324 5.041 3.777 4.074 3.153 5.873 2.465 4.681 3.707 5.036 0
Totale 164.726